DavidG.HillMDFCCP
Pulmonology • Waterbury, CTAsthma & COPD, Critical Care Medicine, Pleural Disease
Partner and Director Clinical Research at Waterbury Pulmonary Associates
Dr. Hill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
170 Grandview Ave
Waterbury, CT 06708Phone+1 203-759-3666Fax+1 203-759-3671
Summary
- Dr. David Hill is a pulmonologist in Waterbury, CT and is affiliated with multiple hospitals in the area, including Saint Mary's Hospital and Waterbury Hospital. He received his medical degree from Medical College of Pennsylvania and has been in practice 26 years. He specializes in critical care medicine and pleural disease and is experienced in asthma, chronic obstructive pulmonary disease, critical care medicine, biomedical research, and chronic cough.
Education & Training
Yale-New Haven Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1994 - 1997
University of ConnecticutResidency, Internal Medicine, 1991 - 1994
MCP-Hahnemann College of MedicineClass of 1991
Certifications & Licensure
CT State Medical License 1993 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MediTouch HER, HealthFusion, Inc., 2013
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 6 citationsDetection of early-stage lung cancer in sputum using automated flow cytometry and machine learning.Madeleine E Lemieux, Xavier T Reveles, Jennifer Rebeles, Lydia H Bederka, Patricia R Araujo
Respiratory Research. 2023-01-21 - 2 citationsSputum analysis by flow cytometry; an effective platform to analyze the lung environment.Lydia H Bederka, Jamila R Sanchez, Jennifer Rebeles, Patricia R Araujo, Marcia H Grayson
Plos One. 2022-01-01 - 2 citationsSingle-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis.Samuel Bardsley, Gerard J Criner, David M G Halpin, MeiLan K Han, Nicola A Hanania
Respiratory Medicine. 2022-12-01
Press Mentions
Staffing Problems Persist at Prospect-Owned Waterbury Hospital, Union Leader SaysSeptember 26th, 2024- CT Ranks First in Lung Cancer Survival but Report Shows Outreach to Underserved Communities NecessaryNovember 17th, 2021
- American Lung Association Launches $25 Million Fund to Fight COVID-19, Future PandemicsApril 10th, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
